<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Prostate Cancer Prostatic Dis</journal-id><journal-id journal-id-type="iso-abbrev">Prostate Cancer Prostatic Dis</journal-id><journal-title-group><journal-title>Prostate Cancer and Prostatic Diseases</journal-title></journal-title-group><issn pub-type="ppub">1365-7852</issn><issn pub-type="epub">1476-5608</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39025926</article-id><article-id pub-id-type="pmc">PMC11860213</article-id>
<article-id pub-id-type="publisher-id">868</article-id><article-id pub-id-type="doi">10.1038/s41391-024-00868-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Intraoperative technologies to assess margin status during radical prostatectomy &#x02013; a narrative review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8963-5445</contrib-id><name><surname>Windisch</surname><given-names>O.</given-names></name><address><email>o.windisch@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Diana</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7033-1380</contrib-id><name><surname>Tilki</surname><given-names>D.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Marra</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1272-7154</contrib-id><name><surname>Martini</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Valerio</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01swzsf04</institution-id><institution-id institution-id-type="GRID">grid.8591.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2175 2154</institution-id><institution>Service of Urology, Department of Surgery, </institution><institution>Geneva University Hospitals, </institution></institution-wrap>Gen&#x000e8;ve, Switzerland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01swzsf04</institution-id><institution-id institution-id-type="GRID">grid.8591.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2175 2154</institution-id><institution>Faculty of Medicine, </institution><institution>Geneva University, </institution></institution-wrap>Gen&#x000e8;ve, Switzerland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01zgy1s35</institution-id><institution-id institution-id-type="GRID">grid.13648.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 2180 3484</institution-id><institution>Martini-Klinik Prostate Cancer Center, </institution><institution>University Hospital Hamburg Eppendorf, </institution></institution-wrap>Hamburg, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03wjwyj98</institution-id><institution-id institution-id-type="GRID">grid.480123.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0553 3068</institution-id><institution>Department of Urology, </institution><institution>University Hospital Hamburg-Eppendorf, </institution></institution-wrap>Hamburg, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00jzwgz36</institution-id><institution-id institution-id-type="GRID">grid.15876.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0688 7552</institution-id><institution>Department of Urology, </institution><institution>Koc University Hospital, </institution></institution-wrap>Istanbul, Turkey </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/048tbm396</institution-id><institution-id institution-id-type="GRID">grid.7605.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2336 6580</institution-id><institution>Department of Surgical Sciences, </institution><institution>San Giovanni Battista Hospital and University of Turin, </institution></institution-wrap>Turin, Italy </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04twxam07</institution-id><institution-id institution-id-type="GRID">grid.240145.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2291 4776</institution-id><institution>Department of Urology, </institution><institution>University of Texas MD Anderson Cancer Center, </institution></institution-wrap>Houston, TX USA </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>28</volume><issue>1</issue><fpage>81</fpage><lpage>88</lpage><history><date date-type="received"><day>19</day><month>3</month><year>2024</year></date><date date-type="rev-recd"><day>29</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>5</day><month>7</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02013;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02013;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Positive surgical margin (PSM) is a frequent concern for surgeons performing radical prostatectomy for prostate cancer (PCa). PSM are recognized as risk factors for earlier biochemical recurrence and expose patients to adjuvant or salvage treatments such as external radiotherapy and hormonotherapy. Several strategies have been established to reduce PSM rate, while still allowing safe nerve-sparing surgery. Precise preoperative staging by multiparametric magnetic resonance imaging (mpMRI) and fusion biopsy is recommended to identify suspicious areas of extracapsular extension (ECE) that warrant special attention during dissection. However, even with optimal imaging, ECE can be missed, some cancers are not well defined or visible, and capsular incision during surgery remains an issue. Hence, intraoperative frozen section techniques, such as the neurovascular structure-adjacent frozen section examination (NeuroSAFE) have been developed and lately widely disseminated. The NeuroSAFE technique reduces PSM rate while allowing higher rate of nerve-sparing surgery. However, its use is limited to high volume or expert center because of its high barrier-to-entry in terms of logistics, human resources and expertise, as well as cost. Also, NeuroSAFE is a time-consuming process, even in expert hands. To address these issues, several technologies have been developed for an ex vivo and in vivo use. Ex vivo technology such as fluorescent confocal microscopy and intraoperative PET-CT require the extraction of the specimen for preparation, and digital images acquisition. In vivo technology, such as augmented reality based on mpMRI images and PSMA-fluorescent guided surgery have the advantage to provide an intracorporeal analysis of the completeness of the resection. The current manuscript provides a narrative review of established techniques, and details several new and promising techniques for intraoperative PSM assessment.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Prostate cancer</kwd><kwd>Cancer therapy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Positive surgical margin (PSM) is a frequent surgeon concern, that has been reported to occur between 14&#x02013;24% of the cases in high-volume center with experts surgeons, while higher number have been reported for locally advanced disease or less expert centers [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Neurovascular bundle (NVB) sparing surgery is recognized as a safe procedure in the hand of expert surgeon in well-selected patient, but has been associated with increased rate of PSM in less experts surgeons during their learning curve [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>] While extensive and multifocal PSM were long demonstrated as associated with increased BCR and successive or salvage treatments, recent evidence showed that limited (&#x0003c;&#x02009;3&#x02009;mm) PSM were also significantly associated with increased BCR [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] Evidence evaluating patient anxiety after PSM announcement is lacking, but incomplete resection can be a stressful experience for patients, and a challenge to face for surgeons.</p><p id="Par3">Several locations are more prone to PSM on the radical prostatectomy (RP) specimen; the most frequent site being the apex and the second one the posterolateral margins of the prostate where the NVB lie. The main reason for this distribution is related to functional considerations. At the apex, the pseudocapsule ends in a diffuse manner limiting the precise ability to identify its distal end, while the surgeon tries to preserve the maximal functional urethral length. At the posterolateral margin, PSM are mainly observed in case of advanced nerve-sparing surgery or when ECE is present. Other margins location exist (bladder neck, prostate capsule, seminal vesicles) but are less common [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par4">To better plan nerve-sparing surgery approach (intrafascial, interfascial or extrafascial plane), risk and location of ECE has to be assessed. Several preoperative strategies have been developed, frequently based on preoperative imaging or nomograms to predict zonal ECE. In Europe, multiparametric magnetic resonance imaging (mpMRI) is recommended in the diagnostic pathway prior to biopsies and it can help identifying ECE with several distinctive signs (i.e. broad contact of the tumor with the capsule, tumor in periprostatic fat etc.) [<xref ref-type="bibr" rid="CR10">10</xref>]. Other imaging techniques, such as PSMA-PET or micro-ultrasound have also been reported but lack sufficient evidence in the context of PSM assessment [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Several nomograms were also developed to evaluate the risk of side-specific extraprostatic extension [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par5">This is a dilemma in the intraoperative decision-making in which the surgeon must compromise between the functional and the oncological outcome. If an intraoperative assessment of surgical margin was available, the surgeon could push the boundaries of NVB preservation, and at the same time ensure negative margins [<xref ref-type="bibr" rid="CR14">14</xref>]. As high as 80% surgeons reported in a recent survey that they would find useful to have intraoperative technologies to assess for PSM [<xref ref-type="bibr" rid="CR15">15</xref>]. Due to the low performance of unsystematic, cognitive-guided intraoperative frozen section, more systematic techniques have been developed to provide intraoperative assessment of surgical margins ; the most commonly reported being the neurovascular bundle structure-adjacent frozen section examination (NeuroSAFE). While very useful and accurate, the NeuroSAFE requires dedicated expert pathologist, and expensive resources, limiting its widespread use [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par6">Several novel technologies have been developed and reported - in vivo (intracorporeally during the intervention), such as augmented reality with 3-D reconstruction of mpMRI images, or PSMA-fluorescence guided surgery, - or ex vivo (the specimen is extracted from the body and analyzed), such as fluorescent confocal microscopy (FCM) and specimen PET-CT. The current manuscript begins with a narrative review of established techniques, and details new and promising technologies in its second part.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par7">This non-systematic review was performed searching on the Medical Literature Analysis and Retrieval System Online (MEDLINE), Web of Science, and Google scholar using a combination of the following keywords: &#x0201c;frozen section&#x0201d;,&#x0201c;intraoperative&#x0201d;,&#x0201d;real time&#x0201d;,&#x0201d;prostatectomy&#x0201d;,&#x0201d; margin&#x0201d;,&#x0201c;surgical margin&#x0201d;,&#x0201d;technology&#x0201d;,&#x0201d;imaging&#x0201d;,&#x0201d;fluorescence&#x0201d; on December 15th 2023. Furthermore, manual search in the references of the included articles was performed and additional articles deemed relevant were included. The authors have not included all technologies in this non-systematic review, but focused their search on the technologies deemed to be used frequently, have an historical importance, or believed to have a wider use in the near future. The authors decided to stratify modern technologies according to preoperative, intraoperative in vivo or intraoperative ex vivo approach to assess surgical margins. Figures were created with Biorender.com.</p><sec id="Sec3"><title>Preoperative technologies</title><p id="Par8">In the present section, the authors focus on the technologies that are used preoperatively to assess the location(s), extension, and the risk for ECE. These technologies do not provide intraoperative feedback to evaluate the completeness of resection but play a role on the surgical planning.</p><sec id="Sec4"><title>Imaging techniques to improve staging accuracy and detect extraprostatic extension</title><p id="Par9">mpMRI is recommended by the European Association of Urology guidelines within the prostate cancer diagnostic pathway and is therefore widely available before surgery. Despite being generally employed to guide surgery, a 2016 meta-analysis on 75 studies showed that the overall sensitivity for ECE was low (0.57) while the specificity (0.91) was high [<xref ref-type="bibr" rid="CR18">18</xref>]. The low sensitivity resulted in additional recommendations to improve the quality of image acquisition and interpretation, such as the PI-RADS v2.1 revision and the PI-QUAL score, that aims to objectively assess mpMRI quality. When including only the best imaging quality and employing state-of-the-art ECE radiologic criteria, increased sensitivity was reported ; some authors reported that negative mpMRI could completely rule out ECE, while others reported that up to 20% patients still harbor missed ECE on the RP specimen [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. When comparing mpMRI to non-mpMRI diagnostic pathway, conflicting results have been reported, some authors claiming that reduced PSM and higher cancer control can be achieved, while others found similar PSM not allowing to draw definite conclusion [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. No matter the final clinical impact, 26% to 59% of the clinicians considered that mpMRI had an impact on the surgical decision [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par10">Microultrasound, a novel technology using a 29-MHz transrectal probe, has been increasingly adopted to improve identification and characterization of intraprostatic PCa significant lesions [<xref ref-type="bibr" rid="CR12">12</xref>]. Its diagnostic ability, when compared to conventional TRUS that usually performed badly, have been described as superior with a sensitivity, specificity, PPV and NPV of 68.7, 96.3%, 80.8% and 93.1% respectively for the index lesion identification. It has already been used to assess and predict ECE, with a sensitivity of 72.1% and specificity of 88% resulting in an AUC of 80.4 [<xref ref-type="bibr" rid="CR25">25</xref>]. It has not yet been employed in a prospective study to influence NVB preservation.</p><p id="Par11">PSMA-PET-CT is mainly used for nodal or metastatic burden assessment. PSMA PET-CT underperformed mpMRI in detecting ECE in several studies [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. However, PSMA-PET-MRI could represent an interesting alternative with a higher T-staging accuracy than mpMRI alone, with a global accuracy of 82.5%, a T3a accuracy of 79% and T3b of 94% [<xref ref-type="bibr" rid="CR28">28</xref>]. While these results are interesting, the access to such imaging modality is highly variable depending on different countries. While the spatial resolution is best with mpMRI, a recent meta-analysis suggested that PSMA PET-CT is very promising, and that PSMA-PET-MRI shows a better sensitivity and specificity for ECE detection than conventional mpMRI [<xref ref-type="bibr" rid="CR29">29</xref>].</p></sec><sec id="Sec5"><title>Nomograms to predict extracapsular extension</title><p id="Par12">Several prediction models have been described and further assessed in external validation studies, using several common variables (clinical T-stage, PSA, cancer burden using different metrics on biopsy etc.) and most of them including imaging-derived variables. While these nomograms perform adequately on the base population they were developed for, most of them present with significantly lesser accuracy at external validation. Two external validations studies of the promising models were published in 2019 and 2023. The best performing models (Patel, Pak, Martini, Soeterik) had an AUC ranging from 0.73 to 0.77 [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. While some authors developed interface-friendly scores to use (<ext-link ext-link-type="uri" xlink:href="http://www.prece.it">www.prece.it</ext-link>) to face the challenge of applying nomograms in real-life, the accuracy of even the best performing model still remains imperfect. Thus, nomograms provide further guidance in the nerve-sparing decision but are often not sufficient ; they ask for more precise technologies that are more adapted to each individual patient [<xref ref-type="bibr" rid="CR31">31</xref>].</p></sec></sec><sec id="Sec6"><title>Intraoperative strategies</title><p id="Par13">Intraoperative strategies provide immediate feedback with regard to the completeness of resection, and an opportunity for additional resection in case of residual tumor detection. Ideal new technologies should be usable in vivo, be fast to use (minutes), in real-time, easy, provide an assessment of the entire surface of the prostate, whilst maintaining a high accuracy and without damaging the specimen for successive conventional histopathological examination [<xref ref-type="bibr" rid="CR32">32</xref>]. This section will focus on modern &#x0201c;ex vivo&#x0201d; and &#x0201c;in vivo&#x0201d; technologies already adopted in clinical use as well as undergoing clinical implementation for intraoperative surgical margin assessment.</p><sec id="Sec7"><title>Ex vivo (extraction of the specimen required)</title><p id="Par14">The technologies that are performed ex vivo rely on the previous extraction of the specimen. Whilst the ex-vivo analysis is ongoing the surgeon can either wait the results or finish the RP. Hence, timing required for the analysis are crucial. Extracting the specimen is a short operation when using appropriate surgical techniques with a very low risk of incisional hernia (&#x0003c;&#x02009;1%) [<xref ref-type="bibr" rid="CR33">33</xref>]. Ex vivo analysis allows for the detection of PSM, but does not allow an immediate in vivo visualization of where the suspicious residual tumor may lie. Orientation of the specimen, as well as the corresponding NVB has to be performed to guide the additional resection, but no standardized technique has been established since several techniques and technology co-exist. In addition, the objective of re-resection to obtain negative surgical margins is believed to be a safe procedure and bring oncological benefits, but these oncological benefits have not yet been proven [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec8"><title>Intraoperative frozen section (Gold-standard)</title><p id="Par15">Intraoperative frozen section (FS) is the most frequently used procedure to assess surgical margins and is considered the gold-standard technique [<xref ref-type="bibr" rid="CR24">24</xref>]. After freezing the specimen at a &#x02212;16&#x000b0; to &#x02212;20&#x02009;&#x000b0;C, it is cut in multiple sections that are then stained using Hematoxylin and Eosin for microscopic evaluation. Since assessing the whole circumference of the specimen is time-consuming, and the procedure has to be performed intraoperatively without delaying too much the advance of the surgery, only specific areas of the gland at risk of PSM are examined. A recent systematic review provides a list of the recently published studies that reported FS during prostatectomy [<xref ref-type="bibr" rid="CR35">35</xref>]. It is interesting to note that initially, no standardized techniques were used, and that some authors performed FS only on the apical site, or neurovascular bundle, bladder neck and sometimes a combination of these [<xref ref-type="bibr" rid="CR24">24</xref>]. In 2012, Schlomm reported the standardized technique of neurovascular structure-adjacent frozen examination (NeuroSAFE) that assessed periprostatic tissue, with an accuracy of 97.3%, reducing the PSM rate by a 32% rate (from 22% to 15%) while increasing the ability to provide nerve sparing [<xref ref-type="bibr" rid="CR36">36</xref>]. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> describes the NeuroSAFE technique. Since then, several other studies have reported promising results of the NeuroSAFE [<xref ref-type="bibr" rid="CR35">35</xref>]. To translate this number into clinically meaningful outcomes for patients, a randomized control trial (NEUROSAFE PROOF) is now ongoing, comparing NEUROSAFE against standard of care in terms of recovery of potency after surgery (defined as an IIEF-5&#x02009;&#x02265;&#x02009;22) [<xref ref-type="bibr" rid="CR17">17</xref>]. While valuable, these techniques require expert and available pathology teams, as well as a whole logistics that reduces greatly the number of centers worldwide able to adopt this technique as a standard-of-care.<fig id="Fig1"><label>Fig. 1</label><caption><p>Details the whole process of the Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) technique. H&#x00026;E Hematoxylin &#x00026; Eosin.</p></caption><graphic xlink:href="41391_2024_868_Fig1_HTML" id="d33e432"/></fig></p></sec><sec id="Sec9"><title>Techniques based on intraoperative imaging</title><p id="Par16">Several techniques have been developed to reduce the barriers of intraoperative FS. The main benefit of these techniques is that the preparation does not require a long freezing, fixing and staining process; the analysis is made simpler and quicker to perform than conventional FS and require reduced human and logistics resources. Some recent narrative and systematic review discussed some of the presented techniques [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Since these last reviews, more publications have described the role of ex vivo fluorescence confocal microscopy, intraoperative PET-CT and intraoperative fluorescence. and very recent studies showed the role of the PET-CT specimen imager (Aura-10, XEOS, Belgium) as a promising tool for whole-mount specimen quick analysis [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. The following section details clinically available tools.</p><p id="Par17">Fluorescence confocal microscopy (FCM) was first described in 2019 by Pulia, on prostate biopsies obtained from a RP specimen. Biopsies were prepared by a staining process (immersion in an acridine orange solution for 30&#x02009;s and then rinsed with physiological saline) and then embedded between two glass slides fixed with glue. FCM acquisition was then performed, and acquired digital images were compared to gold-standard histopathological Hematoxylin &#x00026; Eosin (H&#x00026;E) analysis. They showed an 83.3% sensitivity and 93.5% specificity of FCM resulting in a 0.88 area under the curve and a high level of agreement (kappa coefficient of 0.75) [<xref ref-type="bibr" rid="CR40">40</xref>]. The device employed (Vivascope 2500&#x02009;M-G4; Caliber Imaging and Diagnostics, Rochester, NY, USA) uses two different lasers that enable examination according to reflectance (785&#x02009;nm) and fluorescence (488&#x02009;nm). It has a vertical resolution of 4&#x02009;um and maximum depth examination of 200&#x02009;um, with a magnification of up to 550x. A total area of 25&#x02009;x&#x02009;25&#x02009;mm<sup>2</sup> can be acquired in the same image, explaining that several images may be needed to cover the whole gland. After this initial promising experience, Rocco et al reported the use of FCM for prostate biopsies on 54 patients, examining 854 images (427 glass slides and 427 FCM digital images) by 4 expert pathologists with the same process. The results were impressive with a 95.1% accuracy and an almost perfect interreader agreement for cancer detection although the agreement was moderate regarding cancer grade [<xref ref-type="bibr" rid="CR41">41</xref>]. Marenco and colleagues reported similar results on prostate biopsy cores with an 85% positive predictive value (PPV) and 95.1% negative predictive value (NPV) in a median processing and analysis median of 5&#x02009;min [<xref ref-type="bibr" rid="CR42">42</xref>]. After the proof of concept, Rocco et al conducted a study on 20 patients with whole-mount specimen and showed a a perfect agreement between benign and cancerous glands and almost perfect for periprostatic tissue [<xref ref-type="bibr" rid="CR43">43</xref>]. The same team described the use of the Mohs section to perform a flat cut of the neurovascular bundle that doesn&#x02019;t require previous freezing of the specimen Using this technique, 8 patients had an intraoperative analysis of their surgical margins with a total duration of less than 25&#x02009;min. All underwent bilateral complete nerve-sparing and one suspicion of PSM had a re-resection, that finally showed no residual tumor [<xref ref-type="bibr" rid="CR44">44</xref>]. They later reported a standardized surgical technique; during dissection, clips are placed on the specimen and the neurovascular bundle at the same level for orientation and to guide potential re-resection. 3 slices are obtained from the apex using Mohs technique, and from the posterolateral right and left neurovascular bundle. The rest of process is summarized in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. Digitalization of images offer the possibility for remote pathologist interpretation [<xref ref-type="bibr" rid="CR45">45</xref>]. Using the previously described technique, but with a different device (Histolog Scanner, SamanTree Medical SA, Lausanne, Switzerland), with a scanning area of 48&#x02009;x&#x02009;36&#x02009;mm<sup>2</sup> Baas et al compared the performance of intraoperative ex vivo FCM with NeuroSAFE and showed a sensitivity, specificity, PPV and NPV of 86%, 96%, 80%, and 98% respectively. Both techniques found all relevant PSM (defined as residual tumor in the re-resected NVB), while the FCM procedure was significantly shorter (8 vs 50&#x02009;min) [<xref ref-type="bibr" rid="CR46">46</xref>]. Also, other authors reported the LASERfree technique that does not require any tissue cutting, allowing image acquisition by only applying and rotating the prostate posterior and postero-lateral side, to keep the specimen intact for further analysis [<xref ref-type="bibr" rid="CR47">47</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>Details the whole process of ex vivo fluorescence confocal microscopy from specimen extraction to confocal microscopy. It has to be noted that the material is adequately or completely preserved for definitive H&#x00026;E analysis depending on the device used. H&#x00026;E Hematoxylin &#x00026; Eosin.</p></caption><graphic xlink:href="41391_2024_868_Fig2_HTML" id="d33e493"/></fig></p><p id="Par18">PET-CT specimen imager (Aura 10, XEOS, Belgium) is a technology using a PSMA ligand coupled with a radionuclide (either <sup>18</sup>F or <sup>68</sup>Ga) that is injected intravenously, as for PET-PSMA. The injection may be performed before the intervention, with the acquisition of a conventional whole-body irradiation (whole body PET-CT) to assess for positive lymph node or lesions that would contra-indicate the intervention. After the injection, the prostatectomy specimen is retrieved (as well as lymph nodes if indicated) and extracted through an Alexis<sup>TM</sup> port. The specimen is then rinsed from any residual blood clot and oriented in a specific container. Afterwards, digital images in 3 planes (axial, sagittal and coronal) are acquired and interpreted; images from the PET-CT are superimposed to the CT-scan to allow for margin inspection, at an inframillimetric resolution. Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> details this process. This process was first reported by Darr and al. in 2023 and showed the feasibility of this technique to assess prostatectomy specimen for PSM, as well as metastasis in lymph nodes, on 10 consecutive patients that presented with locally advanced prostate cancer, with 6 patients receiving <sup>68</sup>Ga-PSMA-11 and 4 receiving <sup>18</sup>F-PSMA-1007. The device consistently detected the index lesion previously identified on mpMRI and had a 93.5% correlation rate with PET-CT, while the only missed lesion was negative on final pathology, suggesting a possible contamination of the PET-CT by the urine. The resolution was estimated to be 1&#x02009;mm for the PET and 0.2&#x02009;mm for the CT, with final superimposed images acquired in a median time of 12&#x02009;min. It allowed the detection of 4 PSM in pT3 stage patient, that were later confirmed on final histology [<xref ref-type="bibr" rid="CR38">38</xref>]. Oderda et al. also reported to use of the Aura-10 on 3 patients presenting with locally advanced disease operated on for RP and extended pelvic lymph node dissection. The specimen-CT correctly identified a positive lymph nodes, previously seen on whole-body PET-CT, and confirmed the absence of PSM in 2 specimen while the third was uncertain with a final pathological report confirming a complete resection. Median time for image acquisition was also 12&#x02009;min [<xref ref-type="bibr" rid="CR39">39</xref>]. The main issue using this technology is the additional irradiation for the patient, as well as for the assistant surgeon, scrub nurse and surgeon. These issue were assessed previously by the same team, using the same radioligand with another imaging technology (Cerenkov Luminescence), where they showed an acceptable irradiation rate for exposed health professionals, 9.0&#x02009;&#x003bc;Sv (&#x000b1;7.1) for the first assistant, 3.3&#x02009;&#x003bc;Sv (&#x000b1;3.9) for the scrub nurse, 0.7&#x02009;&#x003bc;Sv (&#x000b1;0.7) for the imaging-device management or surgeon [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. The technology is still new, despite having being used in other indications as well (breast, head and neck, pancreatic adenocarcinoma, neuroendocrine tumors). It still requires a standardization on how the signal should be interpreted (SUV range), the optimal time between injection and interpretation, the best radiotracer to use (Gallium showed a better noise-to-background but lesser resolution, while Fluor has a longer half-life that may be useful depending on when the patient should receive the injection). To address this issue, Rodeva and al developed a machine learning algorithm to provide an automatic 3D-segmentation of PET-CT specimen in 6 specimens with a high weighted average precision (97&#x02013;99%), suggesting that the manual segmentation that was performed manually in the previously reported study by Darr (to compare concordance of the SUV signal with definite histology), may be done automatically in the future, allowing for a larger role of machine learning [<xref ref-type="bibr" rid="CR50">50</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>Details the whole process of ex vivo PET-CT specimen from radio-ligand injection to the PET digital images acquisition. It has to be noted that the material is fully preserved for definitive H&#x00026;E analysis. H&#x00026;E Hematoxylin &#x00026; Eosin.</p></caption><graphic xlink:href="41391_2024_868_Fig3_HTML" id="d33e532"/></fig></p></sec><sec id="Sec10"><title>In vivo (Prostatectomy specimen left in place, analysis done intracorporeally)</title><p id="Par19">In vivo analysis has been reported using several technologies such as augmented reality based on mpMRI, as well as fluorescent confocal endomicroscopy. The most recent development in in vivo technology relies on fluorescent probes. To define a successfully developed fluorescent probe, Mandel stated the four following tenets; 1. high specificity and good signal-to-noise ratio, 2. feasibility of real time imaging lasting during the whole procedure, 3. biosafety and low toxicity profile/adverse effects, 4. limited cost allowing for widespread use. When using fluorescence, the Near-InfraRed (NIR) spectrum has the advantage not to hinder normal vision under white light since its spectrum lies outside of visible light [<xref ref-type="bibr" rid="CR51">51</xref>]. The main benefit of an intraoperative in vivo assessment is an easier detection of where the residual tumoral tissue lies, allowing for a targeted additional resection [<xref ref-type="bibr" rid="CR52">52</xref>]. Holding this into account, the current section will detail &#x0201c;in vivo&#x0201d; technologies.</p><sec id="FPar1"><title>MpMRI combined with augmented reality</title><p id="Par20">Several authors showed the feasibility of superimposing 3-D prostate models obtained from previous radiological images (TRUS, mpMRI) as augmented reality models on intraoperative field, allowing a significant reduction in PSM rate [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. The main problem encountered with both imaging modalities is the underestimation of the tumor size on the 3-D modeled prostate and tumors (3-D model tumor volume represented 48% and 82% of the real volume for TRUS and mpMRI respectively). This resulted in the need for better 3-D superimposition that was later described by Porpiglia, by integrating the reconstruction directly in the robotic console through the TilePro option. This allowed the authors to proceed to AR-guided biopsies that confirmed extracapsular location in cT3 patients in 78% of the biopsies [<xref ref-type="bibr" rid="CR55">55</xref>]. After this promising experience, they incorporated elastic fusion in their reconstructed model, allowing to take into account the tissue deformation occurring during the intervention. With this system, they identified 100% of the extracapsular involvement in 20 patients presenting with cT3 disease, compared to a 47% accuracy of a 2D cognitive guided resection [<xref ref-type="bibr" rid="CR56">56</xref>]. Another simple form of augmented reality is the superimposition of an orientable 3-D model, reconstructed by a previous contouring of the prostate and lesions, that can be then oriented and integrated in the Da Vinci Console using the Tilepro function (Intuitive Surgical Inc., Sunnyvale, CA,USA) to better locate the tumor and guide the surgeons. This technique has been effective in reducing PSM (22.5% vs 11.3%) with 35% of the PSM located in mpMRI negative lesions [<xref ref-type="bibr" rid="CR57">57</xref>].</p></sec><sec id="FPar2"><title>Confocal laser endomicroscopy</title><p id="Par21">Mainly reported ex vivo, fluorescence confocal microscopy has also been reported as an in vivo procedure by Lopez in 2016 in a 15 patients cohort. It allowed the assessment of selected prostatic capsule regions, as well as periprostatic tissues (bladder neck, urethral stump, levator ani and obturator nerve). The integration of the technology with the TilePro function of the Da Vinci surgical robot (Intuitive Surgical Inc., Sunnyvale, CA,USA) was described as easy to implement. This technology uses a fiberoptic probe (either 2.6- or 0.85&#x02009;mm diameter), that contain laser bundles, allowing to obtain microscopic images at a 1000-fold magnification when putting the probe in contact of the tissue. As for ex vivo, a preparation of the tissue with fluorescein is required, with an intravenous injection 5&#x02009;min prior to neurovascular bundle dissection [<xref ref-type="bibr" rid="CR58">58</xref>]. To provide better interpretation of the findings, Panarello provided an Ex Vivo Atlas of prostatic and periprostatic tissues to simplify interpretation [<xref ref-type="bibr" rid="CR59">59</xref>]. This technique is also widely used in gastroenterology and has also been used in urology for upper tract urinary cancer in urology. To our knowledge, this technology has not been reported afterwards for prostatectomy, but a clinical trial with unpublished results was launched in 2019 [<xref ref-type="bibr" rid="CR60">60</xref>].</p></sec><sec id="FPar3"><title>PSMA-guided near-infrared (NIR) fluorescence</title><p id="Par22">Mangano reported a first promising use of indocyanine green (ICG) to detect the prostatic artery location inside the NVB. It allowed the detection of 100% of the 62 assessed patients, but could not be directly used for margin assessment [<xref ref-type="bibr" rid="CR61">61</xref>]. A step forward was made when Stibbe first reported in 2023, in a phase 2a trial, the use of OTL78, a PSMA- fluorescent tracer on 18 patients that underwent RP, using the VisionSense near-infrared imaging system (Medtronics, Minneapolis, MN, USA) intraoperatively to assess for cancer location and residual tumor detection after extraction of the specimen. Additional resection of suspicious areas were performed in 12 patients, and 3 of these patients had confirmed cancerous tissue on the re-resected areas. Interestingly, they also looked at time between injection and surgery and reported that all patients that had an injection 24&#x02009;h before surgery and presented with suspicious residual fluorescence had confirmed residual cancer on the re-resection analysis. They showed a decreased performance of residual tissue detection when the injection was performed the same day compared to the previous day, and varying sensitivity depending on ISUP grade, tumor volume and PSMA expression [<xref ref-type="bibr" rid="CR62">62</xref>]. Just after, Nguyen and al reported the use of IS-002, a near-infrared fluorescently labeled PSMA-targeting peptide, in a phase 1 trial. IS-002 was injected 24&#x02009;h before surgery (based on preclinical pharmacokinetic and dynamic data) [<xref ref-type="bibr" rid="CR52">52</xref>]. During RP with extended pelvic lymph node dissection, a fluorescence image-guided technology (Firefly, Intuitive Surgical Inc., Sunnyvale, CA,USA) was used to assess for residual tissue detection during and after specimen extraction, as well as for lymph node dissection. Surgeons had to assess on a Likert scale of 1&#x02013;5 the degree of suspicion when analyzing the images. Using a cut-off of 3 defining &#x0201c;suspect&#x0201d;, they reported a 100% negative predictive value as well as an 80% positive predictive value of residual or locoregional tissue detection. The main advantage was, as previously seen with OTL78, a real-time assessment, with the detection of residual tissue, not detected by conventional white light, allowing for a guided re-resection as well. The principle of fluorescent-guided re-resection is illustrated in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>. The best performance was seen with the smallest dose of 25&#x02009;ug/kg, since increasing doses, resulted in a higher signal intensity but background noise, reducing the positive predictive value and overall accuracy. These two examples provide promising example of selective fluorophores, with good intensity-to-background noise ratio, usable in clinical practice, with a safe administration profile [<xref ref-type="bibr" rid="CR52">52</xref>]. Further research is required to assess the reproducibility of these techniques, to determine whether the re-resection improves the oncological outcomes, and if a functional impact can be observed by adopting this technology.<fig id="Fig4"><label>Fig. 4</label><caption><p>Provides a generic illustration of surgery guided by fluorescent with previous injection of PSMA-coupled fluorophore and possibility of targeted re-resection.</p></caption><graphic xlink:href="41391_2024_868_Fig4_HTML" id="d33e605"/></fig></p></sec></sec></sec></sec><sec id="Sec11" sec-type="conclusion"><title>Conclusion</title><p id="Par23">PSM is a risk factor for earlier biochemical recurrence and one of the rare adjustable factors on which the surgeon can have an impact. While imaging and nomograms play an important role in identifying and predicting extracapsular disease, they have limitations and there is a need to further intraoperative decision-making. Intraoperative surgical margin with the NeuroSAFE technique is useful, reduces the rate of PSM and improves the rate of nerve sparing surgery, but has important barriers-to-entry limiting wide adoption.</p><p id="Par24">Several promising technologies have been reported such as ex vivo confocal microscopy, PET-CT specimen imager to provide a whole prostate assessment allowing for whole specimen analysis in shorter time and with no need for dedicated in-room pathologists. Recently, PSMA-coupled fluorophores allowed for in vivo assessment of residual cancer during prostatectomy and additional resection. While their potential is clear to most clinicians, and the speed of their development impressive, their impact on functional outcome first, through patient reported-outcomes assessment, as well as solid oncological outcomes (biochemical recurrence, adjuvant treatment, mortality), following the IDEAL-D framework should be assessed before widespread adoption.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>OW: conception and design of the study, data acquisition and interpretation, drafting of the manuscript, MD: data acquisition and interpretation, critical revision, DT: data acquisition and interpretation, critical revision, GM: data acquisition and interpretation, critical revision, AM: data acquisition and interpretation, critical revision, MV: conception and design of the study, manuscript drafting, critical revision, supervision. All authors have approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by University of Geneva.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par25">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>AJ</given-names></name><name><surname>Wood</surname><given-names>DP</given-names></name><name><surname>Kattan</surname><given-names>MW</given-names></name><name><surname>Klein</surname><given-names>EA</given-names></name><name><surname>Scardino</surname><given-names>PT</given-names></name><name><surname>Eastham</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy</article-title><source>J Urol</source><year>2009</year><volume>182</volume><fpage>1357</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2009.06.046</pub-id><pub-id pub-id-type="pmid">19683274</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Stephenson AJ, Wood DP, Kattan MW, Klein EA, Scardino PT, Eastham JA, et al. Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy. J Urol. 2009;182:1357&#x02013;63.<pub-id pub-id-type="pmid">19683274</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>RF</given-names></name><name><surname>Rocco</surname><given-names>B</given-names></name><name><surname>Patel</surname><given-names>MB</given-names></name><name><surname>Orvieto</surname><given-names>MA</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Ficarra</surname><given-names>V</given-names></name><etal/></person-group><article-title>Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Critical Review of Outcomes Reported by High-Volume Centers</article-title><source>J Endourol</source><year>2010</year><volume>24</volume><fpage>2003</fpage><pub-id pub-id-type="doi">10.1089/end.2010.0295</pub-id><pub-id pub-id-type="pmid">20942686</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Coelho RF, Rocco B, Patel MB, Orvieto MA, Chauhan S, Ficarra V, et al. Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Critical Review of Outcomes Reported by High-Volume Centers. J Endourol. 2010;24:2003.<pub-id pub-id-type="pmid">20942686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Preston</surname><given-names>MA</given-names></name><name><surname>Breau</surname><given-names>RH</given-names></name><name><surname>Lantz</surname><given-names>AG</given-names></name><name><surname>Morash</surname><given-names>C</given-names></name><name><surname>Gerridzen</surname><given-names>RG</given-names></name><name><surname>Doucette</surname><given-names>S</given-names></name><etal/></person-group><article-title>The association between nerve sparing and a positive surgical margin during radical prostatectomy</article-title><source>Urologic Oncol: Semin Original Investig</source><year>2015</year><volume>33</volume><fpage>18.e1</fpage><lpage>18.e6</lpage><pub-id pub-id-type="doi">10.1016/j.urolonc.2014.09.006</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Preston MA, Breau RH, Lantz AG, Morash C, Gerridzen RG, Doucette S, et al. The association between nerve sparing and a positive surgical margin during radical prostatectomy. Urologic Oncol: Semin Original Investig. 2015;33:18.e1&#x02013;18.e6.</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Vickers A, Bianco F, Cronin A, Eastham J, Klein E, Kattan M, et al. The Learning Curve for Surgical Margins After Open Radical Prostatectomy: Implications for Margin Status as an Oncological End Point. The Journal of Urology [Internet]. 2010 Apr [cited 2024 Jun 9]; Available from: 10.1016/j.juro.2009.12.015.</mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>JE</given-names></name><name><surname>Egger</surname><given-names>S</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name><name><surname>Haynes</surname><given-names>AM</given-names></name><name><surname>Matthews</surname><given-names>J</given-names></name><name><surname>Rasiah</surname><given-names>K</given-names></name><etal/></person-group><article-title>Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases</article-title><source>Eur Urol</source><year>2014</year><volume>65</volume><fpage>521</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2013.10.030</pub-id><pub-id pub-id-type="pmid">24287319</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Thompson JE, Egger S, B&#x000f6;hm M, Haynes AM, Matthews J, Rasiah K, et al. Superior Quality of Life and Improved Surgical Margins Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve: A Prospective Single-surgeon Study of 1552 Consecutive Cases. Eur Urol. 2014;65:521&#x02013;31.<pub-id pub-id-type="pmid">24287319</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>LN</given-names></name><name><surname>Head</surname><given-names>L</given-names></name><name><surname>Witiuk</surname><given-names>K</given-names></name><name><surname>Punjani</surname><given-names>N</given-names></name><name><surname>Mallick</surname><given-names>R</given-names></name><name><surname>Cnossen</surname><given-names>S</given-names></name><etal/></person-group><article-title>The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta-Analysis</article-title><source>J Urol</source><year>2017</year><volume>198</volume><fpage>760</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2017.02.3344</pub-id><pub-id pub-id-type="pmid">28286069</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Nguyen LN, Head L, Witiuk K, Punjani N, Mallick R, Cnossen S, et al. The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta-Analysis. J Urol. 2017;198:760&#x02013;9.<pub-id pub-id-type="pmid">28286069</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Koskas</surname><given-names>Y</given-names></name><name><surname>Lannes</surname><given-names>F</given-names></name><name><surname>Branger</surname><given-names>N</given-names></name><name><surname>Giusiano</surname><given-names>S</given-names></name><name><surname>Guibert</surname><given-names>N</given-names></name><name><surname>Pignot</surname><given-names>G</given-names></name><etal/></person-group><article-title>Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up</article-title><source>BMC Urol</source><year>2019</year><volume>19</volume><fpage>37</fpage><pub-id pub-id-type="doi">10.1186/s12894-019-0470-8</pub-id><pub-id pub-id-type="pmid">31092240</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Koskas Y, Lannes F, Branger N, Giusiano S, Guibert N, Pignot G, et al. Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up. BMC Urol. 2019;19:37.<pub-id pub-id-type="pmid">31092240</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Pellegrino F, Falagario UG, Knipper S, Martini A, Akre O, Egevad L, et al. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years&#x02019; Report from the EAU Robotic Urology Section Scientific Working Group. European Urology Oncology [Internet]. 2023 Dec 27 [cited 2024 Jun 9];0. Available from: <ext-link ext-link-type="uri" xlink:href="https://euoncology.europeanurology.com/article/S2588-9311(23)00287-0/fulltext">https://euoncology.europeanurology.com/article/S2588-9311(23)00287-0/fulltext</ext-link>.</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Sooriakumaran</surname><given-names>P</given-names></name><name><surname>Dev</surname><given-names>HS</given-names></name><name><surname>Skarecky</surname><given-names>D</given-names></name><name><surname>Ahlering</surname><given-names>T</given-names></name></person-group><article-title>The importance of surgical margins in prostate cancer</article-title><source>J Surgical Oncol</source><year>2016</year><volume>113</volume><fpage>310</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1002/jso.24109</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Sooriakumaran P, Dev HS, Skarecky D, Ahlering T. The importance of surgical margins in prostate cancer. J Surgical Oncol. 2016;113:310&#x02013;5.</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Pesapane</surname><given-names>F</given-names></name><name><surname>Standaert</surname><given-names>C</given-names></name><name><surname>De Visschere</surname><given-names>P</given-names></name><name><surname>Villeirs</surname><given-names>G</given-names></name></person-group><article-title>T-staging of prostate cancer: Identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI</article-title><source>Clin Imaging</source><year>2020</year><volume>59</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.clinimag.2019.08.007</pub-id><pub-id pub-id-type="pmid">31715511</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Pesapane F, Standaert C, De Visschere P, Villeirs G. T-staging of prostate cancer: Identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI. Clin Imaging. 2020;59:1&#x02013;7.<pub-id pub-id-type="pmid">31715511</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Arslan</surname><given-names>A</given-names></name><name><surname>Karaarslan</surname><given-names>E</given-names></name><name><surname>G&#x000fc;ner</surname><given-names>AL</given-names></name><name><surname>Sa&#x0011f;l&#x00131;can</surname><given-names>Y</given-names></name><name><surname>Tuna</surname><given-names>MB</given-names></name><name><surname>Kural</surname><given-names>AR</given-names></name></person-group><article-title>Comparing the Diagnostic Performance of Multiparametric Prostate MRI Versus 68Ga-PSMA PET-CT in the Evaluation Lymph Node Involvement and Extraprostatic Extension</article-title><source>Acad Radio</source><year>2022</year><volume>29</volume><fpage>698</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1016/j.acra.2020.07.011</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Arslan A, Karaarslan E, G&#x000fc;ner AL, Sa&#x0011f;l&#x00131;can Y, Tuna MB, Kural AR. Comparing the Diagnostic Performance of Multiparametric Prostate MRI Versus 68Ga-PSMA PET-CT in the Evaluation Lymph Node Involvement and Extraprostatic Extension. Acad Radio. 2022;29:698&#x02013;704.</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Chessa</surname><given-names>F</given-names></name><name><surname>Schiavina</surname><given-names>R</given-names></name><name><surname>Ercolino</surname><given-names>A</given-names></name><name><surname>Gaudiano</surname><given-names>C</given-names></name><name><surname>Giusti</surname><given-names>D</given-names></name><name><surname>Bianchi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of the Novel 29 MHz micro-ultrasound &#x0201c;ExactVuTM&#x0201d; for the detection of clinically significant prostate cancer: A prospective single institutional study. A step forward in the diagnosis of prostate cancer</article-title><source>Archivio Ital di Urologia e Androl</source><year>2021</year><volume>93</volume><fpage>132</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.4081/aiua.2021.2.132</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Chessa F, Schiavina R, Ercolino A, Gaudiano C, Giusti D, Bianchi L, et al. Diagnostic accuracy of the Novel 29 MHz micro-ultrasound &#x0201c;ExactVuTM&#x0201d; for the detection of clinically significant prostate cancer: A prospective single institutional study. A step forward in the diagnosis of prostate cancer. Archivio Ital di Urologia e Androl. 2021;93:132&#x02013;8.</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Diamand</surname><given-names>R</given-names></name><name><surname>Roche</surname><given-names>JB</given-names></name><name><surname>Lievore</surname><given-names>E</given-names></name><name><surname>Lacetera</surname><given-names>V</given-names></name><name><surname>Chiacchio</surname><given-names>G</given-names></name><name><surname>Beatrici</surname><given-names>V</given-names></name><etal/></person-group><article-title>External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy</article-title><source>Eur Urol Focus</source><year>2023</year><volume>9</volume><fpage>309</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2022.09.006</pub-id><pub-id pub-id-type="pmid">36153227</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Diamand R, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol Focus. 2023;9:309&#x02013;16.<pub-id pub-id-type="pmid">36153227</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Schatloff</surname><given-names>O</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Sivaraman</surname><given-names>A</given-names></name><name><surname>Kameh</surname><given-names>D</given-names></name><name><surname>Palmer</surname><given-names>KJ</given-names></name><name><surname>Patel</surname><given-names>VR</given-names></name></person-group><article-title>Anatomic Grading of Nerve Sparing During Robot-Assisted Radical Prostatectomy</article-title><source>Eur Urol</source><year>2012</year><volume>61</volume><fpage>796</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2011.12.048</pub-id><pub-id pub-id-type="pmid">22230713</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Schatloff O, Chauhan S, Sivaraman A, Kameh D, Palmer KJ, Patel VR. Anatomic Grading of Nerve Sparing During Robot-Assisted Radical Prostatectomy. Eur Urol. 2012;61:796&#x02013;802.<pub-id pub-id-type="pmid">22230713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes-Hallett</surname><given-names>A</given-names></name><name><surname>Mayer</surname><given-names>EK</given-names></name><name><surname>Pratt</surname><given-names>P</given-names></name><name><surname>Mottrie</surname><given-names>A</given-names></name><name><surname>Darzi</surname><given-names>A</given-names></name><name><surname>Vale</surname><given-names>J</given-names></name></person-group><article-title>The current and future use of imaging in urological robotic surgery: a survey of the European Association of Robotic Urological Surgeons</article-title><source>Int J Med Robot</source><year>2015</year><volume>11</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/rcs.1596</pub-id><pub-id pub-id-type="pmid">24898193</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Hughes-Hallett A, Mayer EK, Pratt P, Mottrie A, Darzi A, Vale J. The current and future use of imaging in urological robotic surgery: a survey of the European Association of Robotic Urological Surgeons. Int J Med Robot. 2015;11:8&#x02013;14.<pub-id pub-id-type="pmid">24898193</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Dinneen</surname><given-names>E</given-names></name><name><surname>Haider</surname><given-names>A</given-names></name><name><surname>Grierson</surname><given-names>J</given-names></name><name><surname>Freeman</surname><given-names>A</given-names></name><name><surname>Oxley</surname><given-names>J</given-names></name><name><surname>Briggs</surname><given-names>T</given-names></name><etal/></person-group><article-title>NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial</article-title><source>BJU Int</source><year>2021</year><volume>127</volume><fpage>676</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1111/bju.15256</pub-id><pub-id pub-id-type="pmid">32985121</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Dinneen E, Haider A, Grierson J, Freeman A, Oxley J, Briggs T, et al. NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial. BJU Int. 2021;127:676&#x02013;86.<pub-id pub-id-type="pmid">32985121</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Dinneen</surname><given-names>E</given-names></name><name><surname>Grierson</surname><given-names>J</given-names></name><name><surname>Almeida-Magana</surname><given-names>R</given-names></name><name><surname>Clow</surname><given-names>R</given-names></name><name><surname>Haider</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>C</given-names></name><etal/></person-group><article-title>NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer</article-title><source>Trials</source><year>2022</year><volume>23</volume><fpage>584</fpage><pub-id pub-id-type="doi">10.1186/s13063-022-06421-7</pub-id><pub-id pub-id-type="pmid">35869497</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Dinneen E, Grierson J, Almeida-Magana R, Clow R, Haider A, Allen C, et al. NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer. Trials. 2022;23:584.<pub-id pub-id-type="pmid">35869497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>de Rooij</surname><given-names>M</given-names></name><name><surname>Hamoen</surname><given-names>EHJ</given-names></name><name><surname>Witjes</surname><given-names>JA</given-names></name><name><surname>Barentsz</surname><given-names>JO</given-names></name><name><surname>Rovers</surname><given-names>MM</given-names></name></person-group><article-title>Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis</article-title><source>Eur Urol</source><year>2016</year><volume>70</volume><fpage>233</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2015.07.029</pub-id><pub-id pub-id-type="pmid">26215604</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">de Rooij M, Hamoen EHJ, Witjes JA, Barentsz JO, Rovers MM. Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. Eur Urol. 2016;70:233&#x02013;45.<pub-id pub-id-type="pmid">26215604</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Windisch</surname><given-names>O</given-names></name><name><surname>Benamran</surname><given-names>D</given-names></name><name><surname>Dariane</surname><given-names>C</given-names></name><name><surname>Favre</surname><given-names>MM</given-names></name><name><surname>Djouhri</surname><given-names>M</given-names></name><name><surname>Chevalier</surname><given-names>M</given-names></name><etal/></person-group><article-title>Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study</article-title><source>Eur Urol Open Sci</source><year>2023</year><volume>47</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.euros.2022.11.013</pub-id><pub-id pub-id-type="pmid">36601048</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, et al. Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study. Eur Urol Open Sci. 2023;47:94&#x02013;101.<pub-id pub-id-type="pmid">36601048</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Dinneen</surname><given-names>E</given-names></name><name><surname>Allen</surname><given-names>C</given-names></name><name><surname>Strange</surname><given-names>T</given-names></name><name><surname>Heffernan-Ho</surname><given-names>D</given-names></name><name><surname>Banjeglav</surname><given-names>J</given-names></name><name><surname>Lindsay</surname><given-names>J</given-names></name><etal/></person-group><article-title>Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy</article-title><source>Diagnostics</source><year>2022</year><volume>12</volume><fpage>1057</fpage><pub-id pub-id-type="doi">10.3390/diagnostics12051057</pub-id><pub-id pub-id-type="pmid">35626214</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Dinneen E, Allen C, Strange T, Heffernan-Ho D, Banjeglav J, Lindsay J, et al. Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy. Diagnostics. 2022;12:1057.<pub-id pub-id-type="pmid">35626214</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Gietelink</surname><given-names>L</given-names></name><name><surname>Jansen</surname><given-names>BHE</given-names></name><name><surname>Oprea-Lager</surname><given-names>DE</given-names></name><name><surname>Nieuwenhuijzen</surname><given-names>JA</given-names></name><name><surname>Vis</surname><given-names>AN</given-names></name></person-group><article-title>Preoperative multiparametric MRI does not lower positive surgical margin rate in a large series of patients undergoing robot-assisted radical prostatectomy</article-title><source>J Robot Surg</source><year>2022</year><volume>16</volume><fpage>273</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s11701-020-01184-2</pub-id><pub-id pub-id-type="pmid">33811618</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Gietelink L, Jansen BHE, Oprea-Lager DE, Nieuwenhuijzen JA, Vis AN. Preoperative multiparametric MRI does not lower positive surgical margin rate in a large series of patients undergoing robot-assisted radical prostatectomy. J Robot Surg. 2022;16:273&#x02013;8.<pub-id pub-id-type="pmid">33811618</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>HD</given-names></name><name><surname>Okabe</surname><given-names>Y</given-names></name><name><surname>Rac</surname><given-names>G</given-names></name><name><surname>Pahouja</surname><given-names>G</given-names></name><name><surname>Desai</surname><given-names>S</given-names></name><name><surname>Shea</surname><given-names>SM</given-names></name><etal/></person-group><article-title>MRI versus non-MRI diagnostic pathways before radical prostatectomy: Impact on nerve-sparing, positive surgical margins, and biochemical recurrence</article-title><source>Urol Oncol</source><year>2023</year><volume>41</volume><fpage>104.e19</fpage><lpage>104.e27</lpage><pub-id pub-id-type="doi">10.1016/j.urolonc.2022.10.012</pub-id><pub-id pub-id-type="pmid">36372633</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Patel HD, Okabe Y, Rac G, Pahouja G, Desai S, Shea SM, et al. MRI versus non-MRI diagnostic pathways before radical prostatectomy: Impact on nerve-sparing, positive surgical margins, and biochemical recurrence. Urol Oncol. 2023;41:104.e19&#x02013;104.e27.<pub-id pub-id-type="pmid">36372633</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Kozikowski</surname><given-names>M</given-names></name><name><surname>Malewski</surname><given-names>W</given-names></name><name><surname>Michalak</surname><given-names>W</given-names></name><name><surname>Dobruch</surname><given-names>J</given-names></name></person-group><article-title>Clinical utility of MRI in the decision-making process before radical prostatectomy: Systematic review and meta-analysis</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><fpage>e0210194</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0210194</pub-id><pub-id pub-id-type="pmid">30615661</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kozikowski M, Malewski W, Michalak W, Dobruch J. Clinical utility of MRI in the decision-making process before radical prostatectomy: Systematic review and meta-analysis. PLoS One. 2019;14:e0210194.<pub-id pub-id-type="pmid">30615661</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Eissa</surname><given-names>A</given-names></name><name><surname>Zoeir</surname><given-names>A</given-names></name><name><surname>Sighinolfi</surname><given-names>MC</given-names></name><name><surname>Puliatti</surname><given-names>S</given-names></name><name><surname>Bevilacqua</surname><given-names>L</given-names></name><name><surname>Del Prete</surname><given-names>C</given-names></name><etal/></person-group><article-title>Real-time&#x0201d; Assessment of Surgical Margins During Radical Prostatectomy: State-of-the-Art</article-title><source>Clin Genitourin Cancer</source><year>2020</year><volume>18</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.clgc.2019.07.012</pub-id><pub-id pub-id-type="pmid">31784282</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Eissa A, Zoeir A, Sighinolfi MC, Puliatti S, Bevilacqua L, Del Prete C, et al. Real-time&#x0201d; Assessment of Surgical Margins During Radical Prostatectomy: State-of-the-Art. Clin Genitourin Cancer. 2020;18:95&#x02013;104.<pub-id pub-id-type="pmid">31784282</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Fasulo</surname><given-names>V</given-names></name><name><surname>Buffi</surname><given-names>NM</given-names></name><name><surname>Regis</surname><given-names>F</given-names></name><name><surname>Paciotti</surname><given-names>M</given-names></name><name><surname>Persico</surname><given-names>F</given-names></name><name><surname>Maffei</surname><given-names>D</given-names></name><etal/></person-group><article-title>Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study</article-title><source>World J Urol</source><year>2022</year><volume>40</volume><fpage>435</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s00345-021-03890-4</pub-id><pub-id pub-id-type="pmid">35001161</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Fasulo V, Buffi NM, Regis F, Paciotti M, Persico F, Maffei D, et al. Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study. World J Urol. 2022;40:435&#x02013;42.<pub-id pub-id-type="pmid">35001161</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Sonni</surname><given-names>I</given-names></name><name><surname>Felker</surname><given-names>ER</given-names></name><name><surname>Lenis</surname><given-names>AT</given-names></name><name><surname>Sisk</surname><given-names>AE</given-names></name><name><surname>Bahri</surname><given-names>S</given-names></name><name><surname>Allen-Auerbach</surname><given-names>M</given-names></name><etal/></person-group><article-title>Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial</article-title><source>J Nucl Med</source><year>2022</year><volume>63</volume><fpage>847</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.2967/jnumed.121.262398</pub-id><pub-id pub-id-type="pmid">34649942</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Sonni I, Felker ER, Lenis AT, Sisk AE, Bahri S, Allen-Auerbach M, et al. Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial. J Nucl Med. 2022;63:847&#x02013;54.<pub-id pub-id-type="pmid">34649942</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Ucar</surname><given-names>T</given-names></name><name><surname>Gunduz</surname><given-names>N</given-names></name><name><surname>Demirci</surname><given-names>E</given-names></name><name><surname>Culpan</surname><given-names>M</given-names></name><name><surname>Gunel</surname><given-names>H</given-names></name><name><surname>Kir</surname><given-names>G</given-names></name><etal/></person-group><article-title>Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study</article-title><source>Prostate</source><year>2022</year><volume>82</volume><fpage>1462</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/pros.24420</pub-id><pub-id pub-id-type="pmid">35915579</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Ucar T, Gunduz N, Demirci E, Culpan M, Gunel H, Kir G, et al. Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study. Prostate. 2022;82:1462&#x02013;8.<pub-id pub-id-type="pmid">35915579</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Grubm&#x000fc;ller</surname><given-names>B</given-names></name><name><surname>Baltzer</surname><given-names>P</given-names></name><name><surname>Hartenbach</surname><given-names>S</given-names></name><name><surname>D&#x02019;Andrea</surname><given-names>D</given-names></name><name><surname>Helbich</surname><given-names>TH</given-names></name><name><surname>Haug</surname><given-names>AR</given-names></name><etal/></person-group><article-title>PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact</article-title><source>Clin Cancer Res</source><year>2018</year><volume>24</volume><fpage>6300</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-0768</pub-id><pub-id pub-id-type="pmid">30139879</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Grubm&#x000fc;ller B, Baltzer P, Hartenbach S, D&#x02019;Andrea D, Helbich TH, Haug AR, et al. PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact. Clin Cancer Res. 2018;24:6300&#x02013;7.<pub-id pub-id-type="pmid">30139879</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>KM</given-names></name><name><surname>So</surname><given-names>WZ</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Yap</surname><given-names>DWT</given-names></name><name><surname>Takwoingi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis</article-title><source>Eur Urol</source><year>2023</year><volume>84</volume><fpage>36</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2023.03.001</pub-id><pub-id pub-id-type="pmid">37032189</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Chow KM, So WZ, Lee HJ, Lee A, Yap DWT, Takwoingi Y, et al. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2023;84:36&#x02013;48.<pub-id pub-id-type="pmid">37032189</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocco</surname><given-names>B</given-names></name><name><surname>Sighinolfi</surname><given-names>MC</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name><name><surname>Eissa</surname><given-names>A</given-names></name><name><surname>Elsherbiny</surname><given-names>A</given-names></name><name><surname>Zoeir</surname><given-names>A</given-names></name><etal/></person-group><article-title>Is Extraprostatic Extension of Cancer Predictable? A Review of Predictive Tools and an External Validation Based on a Large and a Single Center Cohort of Prostate Cancer Patients</article-title><source>Urology</source><year>2019</year><volume>129</volume><fpage>8</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2019.03.019</pub-id><pub-id pub-id-type="pmid">30928608</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Rocco B, Sighinolfi MC, Sandri M, Eissa A, Elsherbiny A, Zoeir A, et al. Is Extraprostatic Extension of Cancer Predictable? A Review of Predictive Tools and an External Validation Based on a Large and a Single Center Cohort of Prostate Cancer Patients. Urology. 2019;129:8&#x02013;20.<pub-id pub-id-type="pmid">30928608</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocco</surname><given-names>B</given-names></name><name><surname>Sighinolfi</surname><given-names>MC</given-names></name></person-group><article-title>Re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol Focus. 2023;9:309&#x02013;16</article-title><source>Eur Urol Focus</source><year>2023</year><volume>9</volume><fpage>547</fpage><pub-id pub-id-type="doi">10.1016/j.euf.2022.10.014</pub-id><pub-id pub-id-type="pmid">36411205</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Rocco B, Sighinolfi MC. Re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol Focus. 2023;9:309&#x02013;16. Eur Urol Focus. 2023;9:547.<pub-id pub-id-type="pmid">36411205</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>olde Heuvel</surname><given-names>J</given-names></name><name><surname>de Wit-van der Veen</surname><given-names>BJ</given-names></name><name><surname>Huizing</surname><given-names>DMV</given-names></name><name><surname>van der Poel</surname><given-names>HG</given-names></name><name><surname>van Leeuwen</surname><given-names>PJ</given-names></name><name><surname>Bhairosing</surname><given-names>PA</given-names></name><etal/></person-group><article-title>State-of-the-art Intraoperative Imaging Technologies for Prostate Margin Assessment: A Systematic Review</article-title><source>Eur Urol Focus</source><year>2021</year><volume>7</volume><fpage>733</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2020.02.004</pub-id><pub-id pub-id-type="pmid">32088139</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">olde Heuvel J, de Wit-van der Veen BJ, Huizing DMV, van der Poel HG, van Leeuwen PJ, Bhairosing PA, et al. State-of-the-art Intraoperative Imaging Technologies for Prostate Margin Assessment: A Systematic Review. Eur Urol Focus. 2021;7:733&#x02013;41.<pub-id pub-id-type="pmid">32088139</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>GL</given-names></name><name><surname>Musi</surname><given-names>G</given-names></name><name><surname>Mazzoleni</surname><given-names>F</given-names></name><name><surname>Matei</surname><given-names>DV</given-names></name><name><surname>Brescia</surname><given-names>A</given-names></name><name><surname>Detti</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intraoperative Frozen Pathology During Robot-Assisted Laparoscopic Radical Prostatectomy: Can ALEXIS<sup>TM</sup> Trocar Make it Easy and Fast?</article-title><source>J Endourol</source><year>2013</year><volume>27</volume><fpage>1213</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1089/end.2012.0645</pub-id><pub-id pub-id-type="pmid">23808757</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Almeida GL, Musi G, Mazzoleni F, Matei DV, Brescia A, Detti S, et al. Intraoperative Frozen Pathology During Robot-Assisted Laparoscopic Radical Prostatectomy: Can ALEXIS<sup>TM</sup> Trocar Make it Easy and Fast? J Endourol. 2013;27:1213&#x02013;7.<pub-id pub-id-type="pmid">23808757</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Sighinolfi</surname><given-names>MC</given-names></name><name><surname>Eissa</surname><given-names>A</given-names></name><name><surname>Spandri</surname><given-names>V</given-names></name><name><surname>Puliatti</surname><given-names>S</given-names></name><name><surname>Micali</surname><given-names>S</given-names></name><name><surname>Reggiani Bonetti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Positive surgical margin during radical prostatectomy: overview of sampling methods for frozen sections and techniques for the secondary resection of the neurovascular bundles</article-title><source>BJU Int</source><year>2020</year><volume>125</volume><fpage>656</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1111/bju.15024</pub-id><pub-id pub-id-type="pmid">32012426</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Sighinolfi MC, Eissa A, Spandri V, Puliatti S, Micali S, Reggiani Bonetti L, et al. Positive surgical margin during radical prostatectomy: overview of sampling methods for frozen sections and techniques for the secondary resection of the neurovascular bundles. BJU Int. 2020;125:656&#x02013;63.<pub-id pub-id-type="pmid">32012426</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Dinneen</surname><given-names>EP</given-names></name><name><surname>Van Der Slot</surname><given-names>M</given-names></name><name><surname>Adasonla</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Grierson</surname><given-names>J</given-names></name><name><surname>Haider</surname><given-names>A</given-names></name><etal/></person-group><article-title>Intraoperative Frozen Section for Margin Evaluation During Radical Prostatectomy: A Systematic Review</article-title><source>Eur Urol Focus</source><year>2020</year><volume>6</volume><fpage>664</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2019.11.009</pub-id><pub-id pub-id-type="pmid">31787570</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Dinneen EP, Van Der Slot M, Adasonla K, Tan J, Grierson J, Haider A, et al. Intraoperative Frozen Section for Margin Evaluation During Radical Prostatectomy: A Systematic Review. Eur Urol Focus. 2020;6:664&#x02013;73.<pub-id pub-id-type="pmid">31787570</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Schlomm</surname><given-names>T</given-names></name><name><surname>Tennstedt</surname><given-names>P</given-names></name><name><surname>Huxhold</surname><given-names>C</given-names></name><name><surname>Steuber</surname><given-names>T</given-names></name><name><surname>Salomon</surname><given-names>G</given-names></name><name><surname>Michl</surname><given-names>U</given-names></name><etal/></person-group><article-title>Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients</article-title><source>Eur Urol</source><year>2012</year><volume>62</volume><fpage>333</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2012.04.057</pub-id><pub-id pub-id-type="pmid">22591631</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Schlomm T, Tennstedt P, Huxhold C, Steuber T, Salomon G, Michl U, et al. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. Eur Urol. 2012;62:333&#x02013;40.<pub-id pub-id-type="pmid">22591631</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Makary</surname><given-names>J</given-names></name><name><surname>van Diepen</surname><given-names>DC</given-names></name><name><surname>Arianayagam</surname><given-names>R</given-names></name><name><surname>McClintock</surname><given-names>G</given-names></name><name><surname>Fallot</surname><given-names>J</given-names></name><name><surname>Leslie</surname><given-names>S</given-names></name><etal/></person-group><article-title>The evolution of image guidance in robotic-assisted laparoscopic prostatectomy (RALP): a glimpse into the future</article-title><source>J Robot Surg</source><year>2022</year><volume>16</volume><fpage>765</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/s11701-021-01305-5</pub-id><pub-id pub-id-type="pmid">34480674</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Makary J, van Diepen DC, Arianayagam R, McClintock G, Fallot J, Leslie S, et al. The evolution of image guidance in robotic-assisted laparoscopic prostatectomy (RALP): a glimpse into the future. J Robot Surg. 2022;16:765&#x02013;74.<pub-id pub-id-type="pmid">34480674</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Darr</surname><given-names>C</given-names></name><name><surname>Costa</surname><given-names>PF</given-names></name><name><surname>Kahl</surname><given-names>T</given-names></name><name><surname>Moraitis</surname><given-names>A</given-names></name><name><surname>Engel</surname><given-names>J</given-names></name><name><surname>Al-Nader</surname><given-names>M</given-names></name><etal/></person-group><article-title>Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens</article-title><source>Eur Urol Open Sci</source><year>2023</year><volume>54</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.euros.2023.05.017</pub-id><pub-id pub-id-type="pmid">37361199</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Darr C, Costa PF, Kahl T, Moraitis A, Engel J, Al-Nader M, et al. Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens. Eur Urol Open Sci. 2023;54:28&#x02013;32.<pub-id pub-id-type="pmid">37361199</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Oderda</surname><given-names>M</given-names></name><name><surname>Grimaldi</surname><given-names>S</given-names></name><name><surname>Rovera</surname><given-names>G</given-names></name><name><surname>Delsedime</surname><given-names>L</given-names></name><name><surname>D&#x02019;Agate</surname><given-names>D</given-names></name><name><surname>Lavagno</surname><given-names>F</given-names></name><etal/></person-group><article-title>Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager</article-title><source>Urology</source><year>2023</year><volume>182</volume><fpage>e257</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2023.08.013</pub-id><pub-id pub-id-type="pmid">37669707</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Oderda M, Grimaldi S, Rovera G, Delsedime L, D&#x02019;Agate D, Lavagno F, et al. Robot-assisted PSMA-radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager. Urology. 2023;182:e257&#x02013;61.<pub-id pub-id-type="pmid">37669707</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Puliatti</surname><given-names>S</given-names></name><name><surname>Bertoni</surname><given-names>L</given-names></name><name><surname>Pirola</surname><given-names>GM</given-names></name><name><surname>Azzoni</surname><given-names>P</given-names></name><name><surname>Bevilacqua</surname><given-names>L</given-names></name><name><surname>Eissa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ex vivo fluorescence confocal microscopy: the first application for real-time pathological examination of prostatic tissue</article-title><source>BJU Int</source><year>2019</year><volume>124</volume><fpage>469</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1111/bju.14754</pub-id><pub-id pub-id-type="pmid">30908852</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Puliatti S, Bertoni L, Pirola GM, Azzoni P, Bevilacqua L, Eissa A, et al. Ex vivo fluorescence confocal microscopy: the first application for real-time pathological examination of prostatic tissue. BJU Int. 2019;124:469&#x02013;76.<pub-id pub-id-type="pmid">30908852</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocco</surname><given-names>B</given-names></name><name><surname>Sighinolfi</surname><given-names>MC</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name><name><surname>Spandri</surname><given-names>V</given-names></name><name><surname>Cimadamore</surname><given-names>A</given-names></name><name><surname>Volavsek</surname><given-names>M</given-names></name><etal/></person-group><article-title>Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study</article-title><source>Eur Urol Oncol</source><year>2021</year><volume>4</volume><fpage>784</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.euo.2020.08.009</pub-id><pub-id pub-id-type="pmid">32952095</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Rocco B, Sighinolfi MC, Sandri M, Spandri V, Cimadamore A, Volavsek M, et al. Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study. Eur Urol Oncol. 2021;4:784&#x02013;91.<pub-id pub-id-type="pmid">32952095</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Marenco</surname><given-names>J</given-names></name><name><surname>Calatrava</surname><given-names>A</given-names></name><name><surname>Casanova</surname><given-names>J</given-names></name><name><surname>Claps</surname><given-names>F</given-names></name><name><surname>Mascaros</surname><given-names>J</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><etal/></person-group><article-title>Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores</article-title><source>Eur Urol Focus</source><year>2021</year><volume>7</volume><fpage>1254</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2020.08.013</pub-id><pub-id pub-id-type="pmid">32912840</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Marenco J, Calatrava A, Casanova J, Claps F, Mascaros J, Wong A, et al. Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores. Eur Urol Focus. 2021;7:1254&#x02013;9.<pub-id pub-id-type="pmid">32912840</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocco</surname><given-names>B</given-names></name><name><surname>Sighinolfi</surname><given-names>MC</given-names></name><name><surname>Bertoni</surname><given-names>L</given-names></name><name><surname>Spandri</surname><given-names>V</given-names></name><name><surname>Puliatti</surname><given-names>S</given-names></name><name><surname>Eissa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Real-time assessment of surgical margins during radical prostatectomy: a novel approach that uses fluorescence confocal microscopy for the evaluation of peri-prostatic soft tissue</article-title><source>BJU Int</source><year>2020</year><volume>125</volume><fpage>487</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/bju.15000</pub-id><pub-id pub-id-type="pmid">31971342</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Rocco B, Sighinolfi MC, Bertoni L, Spandri V, Puliatti S, Eissa A, et al. Real-time assessment of surgical margins during radical prostatectomy: a novel approach that uses fluorescence confocal microscopy for the evaluation of peri-prostatic soft tissue. BJU Int. 2020;125:487&#x02013;9.<pub-id pub-id-type="pmid">31971342</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocco</surname><given-names>B</given-names></name><name><surname>Sighinolfi</surname><given-names>MC</given-names></name><name><surname>Cimadamore</surname><given-names>A</given-names></name><name><surname>Reggiani Bonetti</surname><given-names>L</given-names></name><name><surname>Bertoni</surname><given-names>L</given-names></name><name><surname>Puliatti</surname><given-names>S</given-names></name><etal/></person-group><article-title>Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins</article-title><source>BJU Int</source><year>2020</year><volume>126</volume><fpage>336</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/bju.15108</pub-id><pub-id pub-id-type="pmid">32401370</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Rocco B, Sighinolfi MC, Cimadamore A, Reggiani Bonetti L, Bertoni L, Puliatti S, et al. Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins. BJU Int. 2020;126:336&#x02013;8.<pub-id pub-id-type="pmid">32401370</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocco</surname><given-names>B</given-names></name><name><surname>Sarchi</surname><given-names>L</given-names></name><name><surname>Assumma</surname><given-names>S</given-names></name><name><surname>Cimadamore</surname><given-names>A</given-names></name><name><surname>Montironi</surname><given-names>R</given-names></name><name><surname>Reggiani Bonetti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique</article-title><source>Eur Urol</source><year>2021</year><volume>80</volume><fpage>724</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2021.03.021</pub-id><pub-id pub-id-type="pmid">33965288</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Rocco B, Sarchi L, Assumma S, Cimadamore A, Montironi R, Reggiani Bonetti L, et al. Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique. Eur Urol. 2021;80:724&#x02013;9.<pub-id pub-id-type="pmid">33965288</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Baas</surname><given-names>DJH</given-names></name><name><surname>Vreuls</surname><given-names>W</given-names></name><name><surname>Sedelaar</surname><given-names>JPM</given-names></name><name><surname>Vrijhof</surname><given-names>HJEJ</given-names></name><name><surname>Hoekstra</surname><given-names>RJ</given-names></name><name><surname>Zomer</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Confocal laser microscopy for assessment of surgical margins during radical prostatectomy</article-title><source>BJU Int</source><year>2023</year><volume>132</volume><fpage>40</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/bju.15938</pub-id><pub-id pub-id-type="pmid">36440864</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Baas DJH, Vreuls W, Sedelaar JPM, Vrijhof HJEJ, Hoekstra RJ, Zomer SF, et al. Confocal laser microscopy for assessment of surgical margins during radical prostatectomy. BJU Int. 2023;132:40&#x02013;6.<pub-id pub-id-type="pmid">36440864</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida-Magana</surname><given-names>R</given-names></name><name><surname>Au</surname><given-names>M</given-names></name><name><surname>Al-Hammouri</surname><given-names>T</given-names></name><name><surname>Dinneen</surname><given-names>K</given-names></name><name><surname>Haider</surname><given-names>A</given-names></name><name><surname>Freeman</surname><given-names>A</given-names></name><etal/></person-group><article-title>Improving fluorescence confocal microscopy for margin assessment during robot-assisted radical prostatectomy: The LaserSAFE technique</article-title><source>BJU Int</source><year>2024</year><volume>133</volume><fpage>677</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/bju.16239</pub-id><pub-id pub-id-type="pmid">38009389</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Almeida-Magana R, Au M, Al-Hammouri T, Dinneen K, Haider A, Freeman A, et al. Improving fluorescence confocal microscopy for margin assessment during robot-assisted radical prostatectomy: The LaserSAFE technique. BJU Int. 2024;133:677&#x02013;9.<pub-id pub-id-type="pmid">38009389</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>PF</given-names></name><name><surname>Fendler</surname><given-names>WP</given-names></name><name><surname>Herrmann</surname><given-names>K</given-names></name><name><surname>Sandach</surname><given-names>P</given-names></name><name><surname>Grafe</surname><given-names>H</given-names></name><name><surname>Grootendorst</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Radiation Protection and Occupational Exposure on 68Ga-PSMA-11&#x02013;Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy</article-title><source>J Nucl Med</source><year>2022</year><volume>63</volume><fpage>1349</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.2967/jnumed.121.263175</pub-id><pub-id pub-id-type="pmid">34916249</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Costa PF, Fendler WP, Herrmann K, Sandach P, Grafe H, Grootendorst MR, et al. Radiation Protection and Occupational Exposure on 68Ga-PSMA-11&#x02013;Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy. J Nucl Med. 2022;63:1349&#x02013;56.<pub-id pub-id-type="pmid">34916249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Darr</surname><given-names>C</given-names></name><name><surname>Harke</surname><given-names>NN</given-names></name><name><surname>Radtke</surname><given-names>JP</given-names></name><name><surname>Yirga</surname><given-names>L</given-names></name><name><surname>Kesch</surname><given-names>C</given-names></name><name><surname>Grootendorst</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Intraoperative 68Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study</article-title><source>J Nucl Med</source><year>2020</year><volume>61</volume><fpage>1500</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.2967/jnumed.119.240424</pub-id><pub-id pub-id-type="pmid">32060212</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Darr C, Harke NN, Radtke JP, Yirga L, Kesch C, Grootendorst MR, et al. Intraoperative 68Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study. J Nucl Med. 2020;61:1500&#x02013;6.<pub-id pub-id-type="pmid">32060212</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Rovera</surname><given-names>G</given-names></name><name><surname>Grimaldi</surname><given-names>S</given-names></name><name><surname>Oderda</surname><given-names>M</given-names></name><name><surname>Finessi</surname><given-names>M</given-names></name><name><surname>Giannini</surname><given-names>V</given-names></name><name><surname>Passera</surname><given-names>R</given-names></name><etal/></person-group><article-title>Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study</article-title><source>Diagnostics (Basel)</source><year>2023</year><volume>13</volume><fpage>3013</fpage><pub-id pub-id-type="doi">10.3390/diagnostics13183013</pub-id><pub-id pub-id-type="pmid">37761380</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Rovera G, Grimaldi S, Oderda M, Finessi M, Giannini V, Passera R, et al. Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study. Diagnostics (Basel). 2023;13:3013.<pub-id pub-id-type="pmid">37761380</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Mandel A, Das C, Ting R, Kaufmann B, Tewari A. Intraoperative Fluorescent Image Guidance for Nerve-Sparing Prostatectomy: A Review of Historical Context and Current Research. J Endourol. 2024;38:30&#x02013;9.</mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">Nguyen HG, van den Berg NS, Antaris AL, Xue L, Greenberg S, Rosenthal JW, et al. First-in-human Evaluation of a Prostate-specific Membrane Antigentargeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy. Eur Urol Oncol. 2024;7:63&#x02013;72.</mixed-citation></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Simpfend&#x000f6;rfer</surname><given-names>T</given-names></name><name><surname>Baumhauer</surname><given-names>M</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M</given-names></name><name><surname>Gutt</surname><given-names>CN</given-names></name><name><surname>Meinzer</surname><given-names>HP</given-names></name><name><surname>Rassweiler</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Augmented reality visualization during laparoscopic radical prostatectomy</article-title><source>J Endourol</source><year>2011</year><volume>25</volume><fpage>1841</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1089/end.2010.0724</pub-id><pub-id pub-id-type="pmid">21970336</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Simpfend&#x000f6;rfer T, Baumhauer M, M&#x000fc;ller M, Gutt CN, Meinzer HP, Rassweiler JJ, et al. Augmented reality visualization during laparoscopic radical prostatectomy. J Endourol. 2011;25:1841&#x02013;5.<pub-id pub-id-type="pmid">21970336</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Ukimura</surname><given-names>O</given-names></name><name><surname>Aron</surname><given-names>M</given-names></name><name><surname>Nakamoto</surname><given-names>M</given-names></name><name><surname>Shoji</surname><given-names>S</given-names></name><name><surname>Abreu</surname><given-names>ALdeC</given-names></name><name><surname>Matsugasumi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Three-dimensional surgical navigation model with TilePro display during robot-assisted radical prostatectomy</article-title><source>J Endourol</source><year>2014</year><volume>28</volume><fpage>625</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1089/end.2013.0749</pub-id><pub-id pub-id-type="pmid">24450285</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Ukimura O, Aron M, Nakamoto M, Shoji S, Abreu ALdeC, Matsugasumi T, et al. Three-dimensional surgical navigation model with TilePro display during robot-assisted radical prostatectomy. J Endourol. 2014;28:625&#x02013;30.<pub-id pub-id-type="pmid">24450285</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Porpiglia</surname><given-names>F</given-names></name><name><surname>Fiori</surname><given-names>C</given-names></name><name><surname>Checcucci</surname><given-names>E</given-names></name><name><surname>Amparore</surname><given-names>D</given-names></name><name><surname>Bertolo</surname><given-names>R</given-names></name></person-group><article-title>Augmented Reality Robot-assisted Radical Prostatectomy: Preliminary Experience</article-title><source>Urology</source><year>2018</year><volume>115</volume><fpage>184</fpage><pub-id pub-id-type="doi">10.1016/j.urology.2018.01.028</pub-id><pub-id pub-id-type="pmid">29548868</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Porpiglia F, Fiori C, Checcucci E, Amparore D, Bertolo R. Augmented Reality Robot-assisted Radical Prostatectomy: Preliminary Experience. Urology. 2018;115:184.<pub-id pub-id-type="pmid">29548868</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Porpiglia</surname><given-names>F</given-names></name><name><surname>Checcucci</surname><given-names>E</given-names></name><name><surname>Amparore</surname><given-names>D</given-names></name><name><surname>Manfredi</surname><given-names>M</given-names></name><name><surname>Massa</surname><given-names>F</given-names></name><name><surname>Piazzolla</surname><given-names>P</given-names></name><etal/></person-group><article-title>Three-dimensional Elastic Augmented-reality Robot-assisted Radical Prostatectomy Using Hyperaccuracy Three-dimensional Reconstruction Technology: A Step Further in the Identification of Capsular Involvement</article-title><source>Eur Urol</source><year>2019</year><volume>76</volume><fpage>505</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2019.03.037</pub-id><pub-id pub-id-type="pmid">30979636</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Porpiglia F, Checcucci E, Amparore D, Manfredi M, Massa F, Piazzolla P, et al. Three-dimensional Elastic Augmented-reality Robot-assisted Radical Prostatectomy Using Hyperaccuracy Three-dimensional Reconstruction Technology: A Step Further in the Identification of Capsular Involvement. Eur Urol. 2019;76:505&#x02013;14.<pub-id pub-id-type="pmid">30979636</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname><given-names>A</given-names></name><name><surname>Falagario</surname><given-names>UG</given-names></name><name><surname>Cumarasamy</surname><given-names>S</given-names></name><name><surname>Jambor</surname><given-names>I</given-names></name><name><surname>Wagaskar</surname><given-names>VG</given-names></name><name><surname>Ratnani</surname><given-names>P</given-names></name><etal/></person-group><article-title>The Role of 3D Models Obtained from Multiparametric Prostate MRI in Performing Robotic Prostatectomy</article-title><source>J Endourol</source><year>2022</year><volume>36</volume><fpage>387</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1089/end.2021.0541</pub-id><pub-id pub-id-type="pmid">34555942</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Martini A, Falagario UG, Cumarasamy S, Jambor I, Wagaskar VG, Ratnani P, et al. The Role of 3D Models Obtained from Multiparametric Prostate MRI in Performing Robotic Prostatectomy. J Endourol. 2022;36387&#x02013;93.<pub-id pub-id-type="pmid">34555942</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>A</given-names></name><name><surname>Zlatev</surname><given-names>DV</given-names></name><name><surname>Mach</surname><given-names>KE</given-names></name><name><surname>Bui</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Rouse</surname><given-names>RV</given-names></name><etal/></person-group><article-title>Intraoperative Optical Biopsy during Robotic Assisted Radical Prostatectomy Using Confocal Endomicroscopy</article-title><source>J Urol</source><year>2016</year><volume>195</volume><fpage>1110</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2015.10.182</pub-id><pub-id pub-id-type="pmid">26626214</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Lopez A, Zlatev DV, Mach KE, Bui D, Liu JJ, Rouse RV, et al. Intraoperative Optical Biopsy during Robotic Assisted Radical Prostatectomy Using Confocal Endomicroscopy. J Urol. 2016;195:1110&#x02013;7.<pub-id pub-id-type="pmid">26626214</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Panarello</surname><given-names>D</given-names></name><name><surname>Comp&#x000e9;rat</surname><given-names>E</given-names></name><name><surname>Seyde</surname><given-names>O</given-names></name><name><surname>Colau</surname><given-names>A</given-names></name><name><surname>Terrone</surname><given-names>C</given-names></name><name><surname>Guillonneau</surname><given-names>B</given-names></name></person-group><article-title>Atlas of Ex Vivo Prostate Tissue and Cancer Images Using Confocal Laser Endomicroscopy: A Project for Intraoperative Positive Surgical Margin Detection During Radical Prostatectomy</article-title><source>Eur Urol Focus</source><year>2020</year><volume>6</volume><fpage>941</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2019.01.004</pub-id><pub-id pub-id-type="pmid">30683530</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Panarello D, Comp&#x000e9;rat E, Seyde O, Colau A, Terrone C, Guillonneau B. Atlas of Ex Vivo Prostate Tissue and Cancer Images Using Confocal Laser Endomicroscopy: A Project for Intraoperative Positive Surgical Margin Detection During Radical Prostatectomy. Eur Urol Focus. 2020;6:941&#x02013;58.<pub-id pub-id-type="pmid">30683530</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Mauna Kea Technologies. Essais Clinique Pour Une Endomicroscopie Robotis&#x000e9;e Dans la red&#x000e9;finition Des Strat&#x000e9;gies d&#x02019;Ex&#x000e9;r&#x000e8;sE (PERS&#x000c9;E) appliqu&#x000e9;e &#x000e0; la Chirurgie de la Prostate [Internet]. clinicaltrials.gov; 2019 Jan [cited 2024 Jan 1]. Report No.: NCT03561857. Available from: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/study/NCT03561857">https://clinicaltrials.gov/study/NCT03561857</ext-link>.</mixed-citation></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Mangano</surname><given-names>MS</given-names></name><name><surname>De Gobbi</surname><given-names>A</given-names></name><name><surname>Beniamin</surname><given-names>F</given-names></name><name><surname>Lamon</surname><given-names>C</given-names></name><name><surname>Ciaccia</surname><given-names>M</given-names></name><name><surname>Maccatrozzo</surname><given-names>L</given-names></name></person-group><article-title>Robot-assisted nerve-sparing radical prostatectomy using near-infrared fluorescence technology and indocyanine green: initial experience</article-title><source>Urologia</source><year>2018</year><volume>85</volume><fpage>29</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.5301/uj.5000244</pub-id><pub-id pub-id-type="pmid">28574144</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Mangano MS, De Gobbi A, Beniamin F, Lamon C, Ciaccia M, Maccatrozzo L. Robot-assisted nerve-sparing radical prostatectomy using near-infrared fluorescence technology and indocyanine green: initial experience. Urologia. 2018;85:29&#x02013;31.<pub-id pub-id-type="pmid">28574144</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Stibbe</surname><given-names>JA</given-names></name><name><surname>de Barros</surname><given-names>HA</given-names></name><name><surname>Linders</surname><given-names>DGJ</given-names></name><name><surname>Bhairosingh</surname><given-names>SS</given-names></name><name><surname>Bekers</surname><given-names>EM</given-names></name><name><surname>van Leeuwen</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial</article-title><source>Lancet Oncol</source><year>2023</year><volume>24</volume><fpage>457</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(23)00102-X</pub-id><pub-id pub-id-type="pmid">37062295</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Stibbe JA, de Barros HA, Linders DGJ, Bhairosingh SS, Bekers EM, van Leeuwen PJ, et al. First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial. Lancet Oncol. 2023;24:457&#x02013;67.<pub-id pub-id-type="pmid">37062295</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>